Drug Regulation Reform--oversight: Orphan drugs
| Author | : United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment |
| Publisher | : |
| Total Pages | : 64 |
| Release | : 1980 |
| Genre | : Drugs |
| ISBN | : |
Drug Regulation Reform Oversight Orphan Drugs
Download Drug Regulation Reform Oversight Orphan Drugs full books in PDF, epub, and Kindle. Read online free Drug Regulation Reform Oversight Orphan Drugs ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Drug Regulation Reform--oversight
| Author | : United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment |
| Publisher | : |
| Total Pages | : 70 |
| Release | : 1980 |
| Genre | : Drugs |
| ISBN | : |
Orphan drugs
| Author | : United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment |
| Publisher | : |
| Total Pages | : 64 |
| Release | : 1980 |
| Genre | : Drugs |
| ISBN | : |
Drug Regulation Reform--oversight: New drug approval process
| Author | : United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment |
| Publisher | : |
| Total Pages | : 34 |
| Release | : 1980 |
| Genre | : Drugs |
| ISBN | : |
Drug Regulation Reform--oversight
| Author | : United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment |
| Publisher | : |
| Total Pages | : 22 |
| Release | : 1980 |
| Genre | : Drug approval |
| ISBN | : |
The Need for FDA Regulatory Reform to Protect the Health and Safety of Americans
| Author | : United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs |
| Publisher | : |
| Total Pages | : 176 |
| Release | : 1996 |
| Genre | : Medical |
| ISBN | : |
To America's Health
| Author | : Henry I. Miller, MD |
| Publisher | : Hoover Institution Press |
| Total Pages | : 128 |
| Release | : 2013-11-01 |
| Genre | : Political Science |
| ISBN | : 081799906X |
A government monopoly over drug regulation is not sacrosanct. This hard-hitting book describes the current regulation of drugs by the FDA and proposes a model for fundamental, yet workable, reform—including an innovative proposal for drug testing and certification review.
Off-label Drug Use and FDA Review of Supplemental Drug Applications
| Author | : United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations |
| Publisher | : |
| Total Pages | : 172 |
| Release | : 1997 |
| Genre | : Medical |
| ISBN | : |
Drug Regulation Reform--oversight
| Author | : United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment |
| Publisher | : |
| Total Pages | : 0 |
| Release | : 1980 |
| Genre | : Drug approval |
| ISBN | : |
Rare Diseases and Orphan Products
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 442 |
| Release | : 2011-04-03 |
| Genre | : Medical |
| ISBN | : 0309158060 |
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
